Merck (MRK) Earnings Analysis: Strong Fundamentals Overshadowed by One-time Charges & AI Innovation
Merck’s (MRK) latest quarterly results saw EPS turn negative due to a massive charge from business development (BD) activities. However, beneath the surface, core product performance and future growth strategies remain more robust than ever, defying initial market concerns. Earnings Summary (Actual vs. Expected) Metric Actual (Current) QoQ Change Vs. Consensus Revenue $ 16.29B -0.7% … Read more